← Leaderboards
Prashant Chittiboina
National Institute Of Neurological Disorders And Stroke
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Neurological Disorders And Stroke
Same institution · by research overlap
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorExcisionMorbidity - Disease RateMagnetic Resonance ImagingOperative Surgical ProceduresAffectBenignImageMedicalBaseNeoplastic CellGeneticProteinsCentral Nervous System NeoplasmsFutureGrowthCohortEpendymomaNatural HistoryFascicleBilateral Vestibular SchwannomaHistone Deacetylase InhibitorMeningiomaGlioma
Grant awards (23)
Improved Diagnosis and Treatment of Cushing's Disease$1,205,601
ZIA · FY2025 · NS · contact PI
Neuro-oncology of Familial Neoplasia Syndromes$855,119
ZIA · FY2025 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$651,156
ZIA · FY2025 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$1,462,124
ZIA · FY2024 · NS · contact PI
Neuro-oncology of Familial Neoplasia Syndromes$551,013
ZIA · FY2024 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$251,990
ZIA · FY2024 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$1,499,462
ZIA · FY2023 · NS · contact PI
Neuro-oncology of Familial Neoplasia Syndromes$549,911
ZIA · FY2023 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$158,379
ZIA · FY2023 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$1,611,437
ZIA · FY2022 · NS · contact PI
Neuro-oncology of Familial Neoplasia Syndromes$588,587
ZIA · FY2022 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$172,361
ZIA · FY2022 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$2,068,980
ZIA · FY2021 · NS · contact PI
Neuro-oncology of Familial Neoplasia Syndromes$796,043
ZIA · FY2021 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$264,075
ZIA · FY2021 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$1,724,810
ZIA · FY2020 · NS · contact PI
Neuro-oncology of Familial Neoplasia Syndromes$513,020
ZIA · FY2020 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$150,698
ZIA · FY2020 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$910,180
ZIA · FY2019 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$876,681
ZIA · FY2018 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$804,009
ZIA · FY2017 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$988,203
ZIA · FY2016 · NS · contact PI
Improved Diagnosis and Treatment of Cushing's Disease$507,399
ZIA · FY2015 · NS · contact PI